<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05797584</url>
  </required_header>
  <id_info>
    <org_study_id>09C923</org_study_id>
    <nct_id>NCT05797584</nct_id>
  </id_info>
  <brief_title>Right Ventricular Contractile Reserve in HF</brief_title>
  <acronym>RISE-HF</acronym>
  <official_title>Valutazione Ecocardiografica Della Riserva Contrattile Del Ventricolo Destro Dopo Carico Volemico Acuto Mediante Sollevamento Passivo Delle Gambe e Durante Infusione di Dobutamina in Pazienti Affetti da Scompenso Cardiaco a Frazione d'Eiezione Ridotta (HFrEF) e Preservata (HFpEF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Auxologico Italiano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Auxologico Italiano</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Right ventricle dysfunction and pulmonary hypertension are related to a worse prognosis in&#xD;
      patients with heart failure with reduced left ventricular ejection fraction (HFrEF) or with&#xD;
      normal left ventricular ejection fraction (HFpEF).&#xD;
&#xD;
      There is preliminary evidence however, that the responses of the right ventricle and of the&#xD;
      pulmonary hemodynamics to stress tests (especially physical stress) may allow to&#xD;
      prognostically stratify these patients, as these responses may bring out latent right&#xD;
      ventricle dysfunction or a normal contractile reserve in patients with dysfunction at rest.&#xD;
&#xD;
      In view of the different pathophysiological mechanisms of the left ventricular dysfunction in&#xD;
      HFpEF and in HFrEF, also the response and the adaptation of the righty ventricle to stress&#xD;
      tests may be different in these two groups of patients.&#xD;
&#xD;
      In this preliminary two groups of 20 patients with HFpEF and HFrEF will be subjected to to&#xD;
      simple stress tests: passive leg raising and inotropic stimulus with dobutamine.&#xD;
&#xD;
      This study intends to analyze, through colorDoppler echocardiography, the behaviour of the&#xD;
      right ventricle and the pulmonary circulation during passive leg raining and infusion of&#xD;
      dobutamine, in a cohort of patients with HFrEF or HFpEF.&#xD;
&#xD;
      The analysis will be focused on the relation between echocardiographic parameters, especially&#xD;
      those concerning right ventricular function and pulmonary hemodynamics, thereby comparing the&#xD;
      responses observed in HFrEF vs HFpEF.&#xD;
&#xD;
      Furthermore, correlations between the above-mentioned echocardiographic parameters and&#xD;
      parameters of daily clinical practice will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Anticipated">March 20, 2026</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Right ventricle (RV) volume - Dobutamine</measure>
    <time_frame>Baseline and at 5 minutes after Dobutamine infusion</time_frame>
    <description>Change in RV volume</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ejection fraction - Dobutamine</measure>
    <time_frame>Baseline and at 5 minutes after Dobutamine infusion</time_frame>
    <description>Change in ejection fraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Right ventricle (RV) volume - Passive leg raining</measure>
    <time_frame>Baseline and at 1 minute after passive leg raising for acute volume load</time_frame>
    <description>Change in RV volume</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ejection fraction - Passive leg raining</measure>
    <time_frame>Baseline and at 1 minute after passive leg raising for acute volume load</time_frame>
    <description>Change in ejection fraction</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>EchocardiocolorDoppler</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>EchocardiocolorDoppler examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dobutamine</intervention_name>
    <description>Dobutamine 5.0 - 10.0 mcg/Kg/min ev</description>
    <arm_group_label>EchocardiocolorDoppler</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Passive leg raising</intervention_name>
    <description>Passive leg raising for acute volume load</description>
    <arm_group_label>EchocardiocolorDoppler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  heart failure with reduced (EF â‰¤40%) or preserved (EF &gt; 50%) ejection fraction&#xD;
&#xD;
          -  echocardiographic acoustic window adequate for evaluation of outcome parameters&#xD;
&#xD;
          -  presence of tricuspid insufficiency which allows assessment of pulmonary artery&#xD;
             systolic pressure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  recent myocardial infraction (&lt;3 months) or unstable angina&#xD;
&#xD;
          -  moderate o severe aortic or mitralic valve disease&#xD;
&#xD;
          -  inadequate acoustic window&#xD;
&#xD;
          -  significant anemia (hemoglobin &lt;10 g/dl)&#xD;
&#xD;
          -  recent heart surgery (&lt; 3 months).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sergio Caravita, MD, PhD</last_name>
    <phone>+390261911</phone>
    <phone_ext>2930</phone_ext>
    <email>s.caravita@auxologico.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale San Luca IRCCS Istituto Auxologico Italiano</name>
      <address>
        <city>Milan</city>
        <state>MI</state>
        <zip>20149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Caravita, MD, PhD</last_name>
      <phone>+390261911</phone>
      <phone_ext>2930</phone_ext>
      <email>s.caravita@auxologico.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 18, 2023</study_first_submitted>
  <study_first_submitted_qc>March 30, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>March 30, 2023</last_update_submitted>
  <last_update_submitted_qc>March 30, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

